Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics
- 10 April 2007
- journal article
- review article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 321 (1-2) , 1-18
- https://doi.org/10.1016/j.jim.2006.12.004
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticariaPublished by Elsevier ,2005
- Changes in intracellular cAMP reported by a Redistribution® assay using a cAMP-dependent protein kinase-green fluorescent protein chimeraCellular Signalling, 2004
- DACH1 Inhibits Transforming Growth Factor-β Signaling through Binding Smad4Journal of Biological Chemistry, 2003
- Development of Quantitative Detection Assays for CYR61 as a New Marker for Benign Prostatic HyperplasiaSLAS Discovery, 2003
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNew England Journal of Medicine, 2002
- Assessment of a simple, non‐toxic alamar blue cell survival assay to monitor tomato cell viabilityPhytochemical Analysis, 2001
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Characterization of Replication-Competent Adenovirus Isolates from Large-Scale Production of a Recombinant Adenoviral VectorHuman Gene Therapy, 1999
- Analysis of Neurotrophin/Receptor Interactions with a gD-Flag-Modified Quantitative Kinase Receptor Activation (gD.KIRA) Enzyme-Linked Immunosorbent AssayExperimental Cell Research, 1997
- Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon AntibodiesNew England Journal of Medicine, 1988